Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Citi
Moodys
Harvard Business School
McKinsey
Express Scripts
Fish and Richardson
Cipla
UBS

Generated: June 20, 2018

DrugPatentWatch Database Preview

SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Sulfamethoxazole And Trimethoprim Double Strength, and what generic alternatives are available?

Sulfamethoxazole And Trimethoprim Double Strength is a drug marketed by Fosun Pharma, Martec Usa Llc, Mutual Pharm, Roxane, Teva, and Watson Labs. and is included in six NDAs.

The generic ingredient in SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH is sulfamethoxazole; trimethoprim. There are twenty-seven drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.
Summary for SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH
Drug patent expirations by year for SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH
Synonyms for SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH
117385-88-3
37341-72-3
38916-35-7
4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide; 5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
4-AMINO-N-(5-METHYL-3-ISOXAZOLYL)-BENZENESULFONAMIDE COMPOUND WITH 5-(3,4,5-TRIMETHOXYBENZYL)PYRIMIDINE-2,4-DIAMINE
4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide; 5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
50641-67-3
50808-41-8
52499-85-1
74711-00-5
8064-90-2
8064-91-3
8076-73-1
A 033
AC1L7D1P
AKOS030548395
Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)- & 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine
Benzenesulfonamide, mixt. with 5-[(3,4,5-trimethoxyphenyl)methyl]-2,4- pyrimidinediamine
CHEBI:3770
CHEMBL58061
Co-Trimazole
Co-Trimoxazole (BAN)
Cotrim.L.U.T.
CTK4J2930
D00285
Epitope ID:141805
HE071457
LS-178642
NSC-618652
NSC618652
SCHEMBL870329
SMX / TMP
SMX-TMP
SMX/TMP
Sulfameth/TMP
Sulfameth/Trimeth
Sulfamethoxazol-trimethoprim
Sulfamethoxazole - trimethoprim mixt
Sulfamethoxazole - trimethoprim mixture
Sulfamethoxazole / TMP
Sulfamethoxazole / trimethoprim
SULFAMETHOXAZOLE AND TRIMETHOPRIM
SULFAMETHOXAZOLE AND TRIMETHOPRIM SINGLE STRENGTH
Sulfamethoxazole mixture with trimethoprim
Sulfamethoxazole Trimethoprim
Sulfamethoxazole-trimeth
Sulfamethoxazole-trimethoprim
SULFAMETHOXAZOLE; TRIMETHOPRIM
SXT
TMP / SMX
TMP & SMX
TMP-SMX
TMP/SMX
Trimethoprim & Sulfamethoxazole
Trimethoprim and sulfamethoxazole
Trimethoprim and sulphamethoxazole
Trimethoprim-sulfamethoxazole
Trimethoprim-sulfamethoxazole combination
Trimethoprim, Sulfamethoxazole Drug Combination
TRIMETHOPRIM/SULFAMETHOXAZOLE
Trimethoprimsulfa
Trimforte
Trimosulfa
WZRJTRPJURQBRM-UHFFFAOYSA-N

US Patents and Regulatory Information for SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fosun Pharma SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH sulfamethoxazole; trimethoprim TABLET;ORAL 018598-004 May 19, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Roxane SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH sulfamethoxazole; trimethoprim TABLET;ORAL 072769-001 Aug 30, 1991 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Martec Usa Llc SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH sulfamethoxazole; trimethoprim TABLET;ORAL 072417-001 Dec 7, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mutual Pharm SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH sulfamethoxazole; trimethoprim TABLET;ORAL 070007-001 Nov 14, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Argus Health
Accenture
Deloitte
Cantor Fitzgerald
US Army
Fuji
Daiichi Sankyo
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.